Center for Drug Evaluation and Research, Office of Biotechnology Products, United States Food and Drug Administration, Silver Spring, Maryland, United States of America.
PLoS One. 2020 Jun 4;15(6):e0233967. doi: 10.1371/journal.pone.0233967. eCollection 2020.
Radiation-induced heart disease presents a significant challenge in the event of an accidental radiation exposure as well as to cancer patients who receive acute doses of irradiation as part of radiation therapy. We utilized the spontaneously hypertensive Wistar-Kyoto rat model, previously shown to demonstrate drug-induced cardiomyopathy, to evaluate the acute and long-term effects of sub-lethal total body gamma irradiation at two, four, and fifty-two weeks. We further examined irreversible oxidative protein carbonylation in the heart immediately following irradiation in the normotensive Wistar-Kyoto rat. Both males and females sustained weight loss and anemic conditions compared to untreated controls over a one-year period as reflected by reduced body weight and low red blood cell count. Increased inflammation was detected by elevated IL-6 serum levels selectively in males at four weeks. Serum cardiac troponin T and I analyses revealed signs of cardiomyopathy at earlier timepoints, but high variability was observed, especially at one year. Echocardiography at two weeks following 5.0Gy treatment revealed a significant decrease in cardiac output in females and a significant decrease in both diastolic and systolic volumes in males. Following 10.0Gy irradiation in the normotensive Wistar-Kyoto rat, the heart tissue showed an increase in total protein oxidative carbonylation accompanied by DNA damage indicated by an increase in γ-H2AX. Using proteomic analyses, we identified several novel proteins which showed a marked difference in carbonylation including those of mitochondrial origin and most notably, cardiac troponin T, one of the key proteins involved in cardiomyocyte contractility. Overall, we present findings of acute oxidative protein damage, DNA damage, cardiac troponin T carbonylation, and long-term cardiomyopathy in the irradiated animals.
放射性心脏病在意外辐射暴露以及接受急性辐射剂量作为放射治疗一部分的癌症患者中是一个重大挑战。我们利用先前显示出可表现出药物诱导性心肌病的自发性高血压 Wistar-Kyoto 大鼠模型,评估了亚致死全身γ照射在两周、四周和五十二周时的急性和长期影响。我们还研究了在正常血压 Wistar-Kyoto 大鼠中照射后立即发生的不可逆氧化蛋白羰基化。与未处理的对照组相比,雄性和雌性大鼠在一年期间都出现体重减轻和贫血状况,表现为体重减轻和红细胞计数降低。在四周时,通过升高的 IL-6 血清水平检测到雄性的炎症增加。血清肌钙蛋白 T 和 I 分析显示出更早时间点的心肌病迹象,但观察到高变异性,特别是在一年时。在接受 5.0Gy 治疗后两周进行的超声心动图显示,雌性的心输出量显著降低,雄性的舒张和收缩容积均显著降低。在正常血压 Wistar-Kyoto 大鼠中接受 10.0Gy 照射后,心脏组织显示总蛋白氧化羰基化增加,同时 DNA 损伤增加,表明 γ-H2AX 增加。通过蛋白质组学分析,我们鉴定出几种在羰基化方面表现出明显差异的新蛋白,包括那些来自线粒体的蛋白,特别是肌钙蛋白 T,它是参与心肌收缩性的关键蛋白之一。总的来说,我们提出了在照射动物中发生的急性氧化蛋白损伤、DNA 损伤、肌钙蛋白 T 羰基化和长期心肌病的发现。